In a significant advance for multiple sclerosis (MS) research, a new study has uncovered a potential link between certain initial symptoms and long-term disability outcomes. The research, published in ...

Jan. 9, 2025 -- Multiple sclerosis (MS) is a complex condition that affects the brain and spinal cord. How does MS impact the body? What are the symptoms of MS? We spoke with Michael Levy, MD, PhD, to ...

In a significant advance for multiple sclerosis (MS) research, a new study has uncovered a potential link between certain initial symptoms and long-term disability outcomes. The research, published in ...

—Evidence from a recent study found that improvement in depression symptoms was associated with a reduction in physical, cognitive, and social fatigue in patients with multiple sclerosis. As ...

NICE has recommended the drug, natalizumab, as an option for adults with relapsing-remitting MS (RRMS) that remains highly active after a full course of at least one disease-modifying therapy, and for ...

Canada: A recent study published in the Multiple Sclerosis Journal has revealed that individuals who experienced psychiatric ...

A long-term study has identified a potential biomarker that could help detect which patients are progressing toward more severe forms of multiple sclerosis.

Chronic respiratory disorders are one of the primary causes of death in patients with multiple sclerosis (MS), but they remain incompletely understood in this population. 1 Identifying diaphragm ...

Cold weather aggravates fatigue and spasticity for some with MS. Learn why and what you can do to stay more comfortable.

New findings show a similar number of injective-related reactions (IRRs) were reported between the use of ofatumumab (Kesimpta) and ocrelizumab (Ocrevus) in the treatment of multiple sclerosis, but ...